These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6165725)

  • 1. Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study.
    J Biol Stand; 1981; 9(2):163-84. PubMed ID: 6165725
    [No Abstract]   [Full Text] [Related]  

  • 2. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-associated poliomyelitis cases.
    Sabin AB
    Bull World Health Organ; 1969; 40(6):947-9. PubMed ID: 5307605
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic characterization of type 3 poliovirus strains isolated (1968-1970) in Italy from vaccinated and unvaccinated patients.
    Marchegiani M; Rocchi G; Santoro R; Puccinelli M
    Ann Inst Pasteur (Paris); 1971 Sep; 121(3):413-8. PubMed ID: 4108589
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.
    Kim-Farley RJ; Bart KJ; Schonberger LB; Orenstein WA; Nkowane BM; Hinman AR; Kew OM; Hatch MH; Kaplan JE
    Lancet; 1984 Dec; 2(8415):1315-7. PubMed ID: 6150330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliomyelitis in hypogammaglobulinemics.
    Wyatt HV
    J Infect Dis; 1973 Dec; 128(6):802-6. PubMed ID: 4765357
    [No Abstract]   [Full Text] [Related]  

  • 10. The problems of poliovirus immunization.
    Fulginiti VA
    Hosp Pract; 1980 Aug; 15(8):61-7. PubMed ID: 6249713
    [No Abstract]   [Full Text] [Related]  

  • 11. Polio vaccine: should New Zealand make the change?
    Baker C; Eberhart-Phillips J
    N Z Med J; 1997 Sep; 110(1051):340-2. PubMed ID: 9323376
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic hybrids of poliovirus.
    Hogle JM
    Nature; 1988 Mar; 332(6159):13-4. PubMed ID: 2831454
    [No Abstract]   [Full Text] [Related]  

  • 13. OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?
    Fescharek R; Budde RK; Arras C
    Vaccine; 1997 Nov; 15(16):1707-8. PubMed ID: 9364670
    [No Abstract]   [Full Text] [Related]  

  • 14. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 16. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
    Mele A; Jefferson T; Franco E; Salmaso S
    Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
    [No Abstract]   [Full Text] [Related]  

  • 18. Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Arya SC; Agarwal N
    Expert Rev Vaccines; 2012 Nov; 11(11):1291. PubMed ID: 23249227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On an epidemic outbreak of poliomyelitis, type 3, in the Voivode County of Poznań in 1968].
    Walter T
    Zentralbl Bakteriol Orig; 1969; 211(2):162-6. PubMed ID: 4318358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Why intratypical differentiation of poliovirus strains?].
    Thraenhart O; Euwert E
    Dtsch Med Wochenschr; 1972 Aug; 97(32):1192-3. PubMed ID: 4339812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.